"Global Non-invasive Prenatal Testing (NIPT) Market Overview:
Global Non-invasive Prenatal Testing (NIPT) Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Non-invasive Prenatal Testing (NIPT) Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Non-invasive Prenatal Testing (NIPT) involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Non-invasive Prenatal Testing (NIPT) Market:
The Non-invasive Prenatal Testing (NIPT) Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Non-invasive Prenatal Testing (NIPT) Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Non-invasive Prenatal Testing (NIPT) Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Non-invasive Prenatal Testing (NIPT) market has been segmented into:
NIPT
By Application, Non-invasive Prenatal Testing (NIPT) market has been segmented into:
Panel 1 Test
Panel 2 Test
and Panel 3 Test
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Non-invasive Prenatal Testing (NIPT) market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Non-invasive Prenatal Testing (NIPT) market.
Top Key Players Covered in Non-invasive Prenatal Testing (NIPT) market are:
F. Hoffmann-La Roche Ltd
BGI Group
Berry Genomics Co. Ltd
Illuminainc.
Eurofins LifeCodexx Gmbh
Naterainc.
Sequenominc.
Axia Women’s Health
Eluthia
BillionToOneinc.
Quest Diagnostics Incorporation
Igenomix
Agilent Technologiesinc
Laboratory Corporation of America Holdings.
PerkinElmerinc.
ThermoFisher Scientific
Yourgene Health PLC
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Non-invasive Prenatal Testing (NIPT) Market by Type
4.1 Non-invasive Prenatal Testing (NIPT) Market Snapshot and Growth Engine
4.2 Non-invasive Prenatal Testing (NIPT) Market Overview
4.3 NIPT
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 NIPT: Geographic Segmentation Analysis
Chapter 5: Non-invasive Prenatal Testing (NIPT) Market by Application
5.1 Non-invasive Prenatal Testing (NIPT) Market Snapshot and Growth Engine
5.2 Non-invasive Prenatal Testing (NIPT) Market Overview
5.3 Panel 1 Test
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Panel 1 Test: Geographic Segmentation Analysis
5.4 Panel 2 Test
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Panel 2 Test: Geographic Segmentation Analysis
5.5 and Panel 3 Test
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 and Panel 3 Test: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Non-invasive Prenatal Testing (NIPT) Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 F. HOFFMANN-LA ROCHE LTD
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 BGI GROUP
6.4 BERRY GENOMICS CO.
6.5 LTD.
6.6 ILLUMINAINC.
6.7 EUROFINS LIFECODEXX GMBH
6.8 NATERAINC.
6.9 SEQUENOMINC.
6.10 AXIA WOMEN’S HEALTH
6.11 ELUTHIA
6.12 BILLIONTOONEINC.
6.13 QUEST DIAGNOSTICS INCORPORATION
6.14 IGENOMIX
6.15 AGILENT TECHNOLOGIESINC
6.16 LABORATORY CORPORATION OF AMERICA HOLDINGS.
6.17 PERKINELMERINC.
6.18 THERMOFISHER SCIENTIFIC
6.19 YOURGENE HEALTH PLC
Chapter 7: Global Non-invasive Prenatal Testing (NIPT) Market By Region
7.1 Overview
7.2. North America Non-invasive Prenatal Testing (NIPT) Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 NIPT
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Panel 1 Test
7.2.5.2 Panel 2 Test
7.2.5.3 and Panel 3 Test
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Non-invasive Prenatal Testing (NIPT) Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 NIPT
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Panel 1 Test
7.3.5.2 Panel 2 Test
7.3.5.3 and Panel 3 Test
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Non-invasive Prenatal Testing (NIPT) Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 NIPT
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Panel 1 Test
7.4.5.2 Panel 2 Test
7.4.5.3 and Panel 3 Test
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Non-invasive Prenatal Testing (NIPT) Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 NIPT
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Panel 1 Test
7.5.5.2 Panel 2 Test
7.5.5.3 and Panel 3 Test
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Non-invasive Prenatal Testing (NIPT) Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 NIPT
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Panel 1 Test
7.6.5.2 Panel 2 Test
7.6.5.3 and Panel 3 Test
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Non-invasive Prenatal Testing (NIPT) Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 NIPT
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Panel 1 Test
7.7.5.2 Panel 2 Test
7.7.5.3 and Panel 3 Test
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Non-invasive Prenatal Testing (NIPT) Scope:
|
Report Data
|
Non-invasive Prenatal Testing (NIPT) Market
|
|
Non-invasive Prenatal Testing (NIPT) Market Size in 2025
|
USD XX million
|
|
Non-invasive Prenatal Testing (NIPT) CAGR 2025 - 2032
|
XX%
|
|
Non-invasive Prenatal Testing (NIPT) Base Year
|
2024
|
|
Non-invasive Prenatal Testing (NIPT) Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
F. Hoffmann-La Roche Ltd, BGI Group, Berry Genomics Co., Ltd., Illuminainc., Eurofins LifeCodexx Gmbh , Naterainc., Sequenominc. ,Axia Women’s Health , Eluthia, BillionToOneinc., Quest Diagnostics Incorporation, Igenomix, Agilent Technologiesinc, Laboratory Corporation of America Holdings., PerkinElmerinc., ThermoFisher Scientific, Yourgene Health PLC.
|
|
Key Segments
|
By Type
NIPT
By Applications
Panel 1 Test
Panel 2 Test
and Panel 3 Test
|
